Benzinga | Aug 12, 2020 04:19PM EDT

Onconova Therapeutics Q2 EPS $(0.04) Misses $(0.03) Estimate, Sales $56.00K Miss $170.00K Estimate

Onconova Therapeutics (NASDAQ:ONTX) reported quarterly losses of $(0.04) per share which missed the analyst consensus estimate of $(0.03) by 33.33 percent. This is a 93.33 percent increase over losses of $(0.60) per share from the same period last year. The company reported quarterly sales of $56.00 thousand which missed the analyst consensus estimate of $170.00 thousand by 67.06 percent. This is a 97.23 percent decrease over sales of $2.02 million the same period last year.